Form 4: DENTSPLY SIRONA Director Sells $915K in Stock

DENTSPLY SIRONA Inc. Director Gregory T. Lucier sold 82,200 shares of common stock for a weighted average price of $11.14 per share, totaling approximately $915,668.

Summary

• Gregory T. Lucier, a Director of DENTSPLY SIRONA Inc. (XRAY), reported a sale of common stock.
• The transaction involved the disposition of 82,200 shares on December 8, 2025.
• The shares were sold at a weighted average price of $11.14 per share, with prices ranging from $11.04 to $11.23.
• The total value of the shares sold is approximately $915,668.
• Following the transaction, Mr. Lucier directly owns 0 shares.
• Indirect beneficial ownership includes 24,560.17 shares via a Family Partnership and 21,000 shares via a Gregory Lucier IRA.
• The share numbers were adjusted to include dividend accruals paid on the shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 3

Explanation: The sale of a significant number of shares by a director is generally viewed as a negative signal, potentially indicating a lack of confidence in the company's future performance or that the stock is overvalued from the insider's perspective.

Negatives

• A Director, Gregory T. Lucier, sold a significant number of shares (82,200 shares) of DENTSPLY SIRONA common stock.
• Insider selling, especially by a director, can be interpreted by the market as a lack of confidence in the company's near-term prospects or that the stock is fully valued.

Risks

• Potential negative market perception due to insider selling by a director.
• The sale could signal a belief by the insider that the stock price may not appreciate significantly in the near future.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. It is specific to DENTSPLY SIRONA Inc. and its director's equity holdings.

Stakeholder Impact

• Shareholders may interpret the director's sale as a negative signal, potentially impacting investor sentiment and the company's stock price.

Key Dates

Recommendation

The sale of a significant block of shares by a director, even if pre-planned under a 10b5-1 plan, typically signals that the insider believes the stock is at least fairly valued, if not fully valued. While not an outright 'sell' signal without further context on the company's fundamentals, it warrants caution and a 'hold' recommendation for investors to reassess their position given this insider activity.

Keywords

DENTSPLY SIRONA, XRAY, Insider Trading, Stock Sale, Director, Form 4, Equity Disposition, Corporate Governance, Shareholder Value